United States · FDA National Drug Code directory
ALECENSA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-130_3159555e-f227-4168-9e96-96f5b705fad2
- Product NDC
- 50242-130
- Form
- CAPSULE
- Composition / generic term
- ALECTINIB HYDROCHLORIDE
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20151211
- Source listing expiry
- 20271231
Source-listed ingredients
- ALECTINIB HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-01) / 240 CAPSULE in 1 BOTTLE, PLASTIC · 50242-130-01
- 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-86) / 240 CAPSULE in 1 BOTTLE, PLASTIC · 50242-130-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →